Sign up to save your podcasts
Or
Share PepTalk 2017 | From Protein Science R&D to Therapeutics: Expert Insights (Part 1)
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
PepTalk 2017 | From Protein Science R&D to Therapeutics: Expert Insights (Part 1)
Dr. Thomas Laue of University of New Hampshire, Bjørn Voldborg of Technical University of Denmark, and Dr. Andrew Fosberry of GlaxoSmithKline speak to Cambridge Healthtech Institute. They are part of “It’s a Wrap”, the closing plenary panel discussion representing various R&D stages at PepTalk: The Protein Science Week, January 9-13 in San Diego, California.
They each consider this question:
What do you see as the next, most promising innovation in your field?
View all episodes
By Cambridge Healthtech Podcasts
5
11 ratings
Dr. Thomas Laue of University of New Hampshire, Bjørn Voldborg of Technical University of Denmark, and Dr. Andrew Fosberry of GlaxoSmithKline speak to Cambridge Healthtech Institute. They are part of “It’s a Wrap”, the closing plenary panel discussion representing various R&D stages at PepTalk: The Protein Science Week, January 9-13 in San Diego, California.
They each consider this question:
What do you see as the next, most promising innovation in your field?